HCW Biologics Inc (HCWB) — Financial Flexibility Index
HCW Biologics Inc (HCWB) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of $-3.36 Million (operating CF $-3.36 Million minus capex $0.00) represents 0% of total liabilities ($21.76 Million). Also explore HCW Biologics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
HCW Biologics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for HCW Biologics Inc across 7 annual periods. Check HCWB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for HCW Biologics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for HCW Biologics Inc. For the full company profile including market capitalisation, see HCW Biologics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | $-13.39 Million | $-13.39 Million | $21.76 Million | ▼ -63.1% |
| 2024 | -0.38x | $-13.97 Million | $-14.23 Million | $37.01 Million | ▲ +65.2% |
| 2023 | -1.08x | $-16.31 Million | $-22.51 Million | $15.05 Million | ▼ -9059.7% |
| 2022 | -0.01x | $-110.98K | $-10.39 Million | $9.38 Million | ▲ +99.7% |
| 2021 | -4.71x | $-10.93 Million | $-10.98 Million | $2.32 Million | ▲ +54.0% |
| 2020 | -10.23x | $-10.24 Million | $-10.43 Million | $1.00 Million | ▼ -105.7% |
| 2019 | -4.98x | $-5.30 Million | $-6.77 Million | $1.07 Million | — |